Aprocitentan [CAS 1103522-45-7]
Partner: MedChemexpress LLC
| CAS No: | 1103522-45-7 |
| Applications: | COVID-19-immunoregulation |
| MW: | 546.19 |
| Formula: | C16H14Br2N6O4S |
| SMILES: | O=S(N)(NC1=NC=NC(OCCOC2=NC=C(Br)C=N2)=C1C3=CC=C(Br)C=C3)=O |
| Purity: | 99.98 |
| Description: | Aprocitentan (ACT-132577) is the major and pharmacologically active metabolite of Macitentan. Aprocitentan is dual ETA/ETB antagonist with IC50s of 3.4 nM and 987 nM, and pA2 valus of 6.7 and 5.5, respectively[1]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
